Effect of alendronate or calcium plus vitamin D3 on thalassemic osteopathy
Not Applicable
- Conditions
- Thalassemic osteopathy
- Registration Number
- SLCTR/2008/018
- Lead Sponsor
- Faculty of Medicine, University of Ruhuna
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow up complete
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
Patients who are diagnosed having thalassemic osteopathy who would admit to Teaching Hospital Karapitiya for regular blood transfusion will be selected for this study
Exclusion Criteria
1. Patient/ parents or guardian who does not give the consent. 2. Inability to comply with the visit schedule.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Bone mineral density changes after administering alendronate, calcium and calcitriol<br> [Every 3 months upto one year after commencement of treatment<br>]<br>
- Secondary Outcome Measures
Name Time Method Reduction of bone pain and fracture risk<br> [At the end of one year after commencing the treatment<br>]<br>